CD40-CD40L interaction in immunity against protozoan infections

Journal of Biomedicine and Biotechnology

Volumn 2007, Issue , 2007, Pages

  Chamekh, Mustapha ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ANTIGEN ANTIBODY REACTION; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; IMMUNOMODULATION; LEISHMANIA; LEISHMANIASIS; PROTOZOAL INFECTION; REVIEW; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

PROTOZOA;

EID: 34250873915     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2007/59430     Document Type: Review

References (48)

1. E. A. Clark J. A. Ledbetter Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proceedings of the National Academy of Sciences of the United States of America 83 12 1986 4494 4498
2. F. Schriever A. S. Freedman G. Freeman Isolated human follicular dendritic cells display a unique antigenic phenotype. Journal of Experimental Medicine 169 6 1989 2043 2058
3. M. R. Alderson R. J. Armitage T. W. Tough L. Strockbine W. C. Fanslow M. K. Spriggs CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. Journal of Experimental Medicine 178 2 1993 669 674
4. D. Hollenbaugh N. Mischel-Petty C. P. Edwards Expression of functional CD40 by vascular endothelial cells. Journal of Experimental Medicine 182 1 1995 33 40
5. C. van Kooten Kooten@rulff2.medfac.leidenuniv.nl J. Banchereau Kooten@rulff2.medfac.leidenuniv.nl Functions of CD40 on B cells, dendritic cells and other cells. Current Opinion in Immunology 9 3 1997 330 337
6. R. J. Armitage W. C. Fanslow L. Strockbine Molecular and biological characterization of a murine ligand for CD40. Nature 357 6373 1992 80 82
7. D. Hollenbaugh L. S. Grosmaire C. D. Kullas The human T cell antigen GP39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of GP39 with B cell co-stimulatory activity. The EMBO Journal 11 12 1992 4313 4321
8. C. van Kooten Kooten@mail.Medfac.LeidenUniv.nl J. Banchereau CD40-CD40 ligand. Journal of Leukocyte Biology 67 1 2000 2 17
9. M. Wykes michellW@qimr.edu.au Why do B cells produce CD40 ligand? Immunology and Cell Biology 81 4 2003 328 331
10. T. M. Foy A. Aruffo J. Bajorath J. E. Buhlmann R. J. Noelle Immune regulation by CD40 and its ligand GP39. Annual Review of Immunology 14 1996 591 617
11. L. B. Clark T. M. Foy R. J. Noelle CD40 and its ligand. Advances in Immunology 63 1996 43 78
12. I. S. Grewal Flavell.Lab@qm.yale.edu R. A. Flavell Richard.Flavell@qm. yale.edu A central role of CD40 ligand in the regulation of CD 4+ T-cell responses. Immunology Today 17 9 1996 410 414
13. M. Cella D. Scheidegger K. Palmer-Lehmann P. Lane A. Lanzavecchia G. Alber Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. Journal of Experimental Medicine 184 2 1996 747 752
14. I. S. Grewal P. Borrow E. G. Pamer M. B. Oldstone R. A. Flavell Richard.Flavell@QM.yale.edu The CD40-CD154 system in anti-infective host defense. Current Opinion in Immunology 9 4 1997 491 497
15. T. H. Watts tania.watts@utoronto.ca TNF/TNFR family members in costimulation of T cell responses. Annual Review of Immunology 23 2005 23 68
16. L. D. Notarangelo M. Duse A. G. Ugazio Immunodeficiency with hyper-IgM (HIM). Immunodeficiency Reviews 3 2 1992 101 121
17. J. Levy T. Espanol-Boren C. Thomas Clinical spectrum of X-linked hyper-IgM syndrome. Journal of Pediatrics 131 1 1997 47 54
18. D. Sacks dsacks@nih.gov N. Noben-Trauth The immunology of susceptibility and resistance to Leishmania major in mice. Nature Reviews Immunology 2 11 2002 845 858
19. K. A. Campbell P. J. Ovendale M. K. Kennedy W. C. Fanslow S. G. Reed C. R. Maliszewski CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4 3 1996 283 289
20. M. Kamanaka P. Yu T. Yasui Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4 3 1996 275 281
21. L. Soong J.-C. Xu I. S. Grewal Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4 3 1996 263 273
22. R. D. Stout stoutr@medserv.east-tenn-st.edu J. Suttles suttlesj@etsuserv.east-tenn-st.edu The many roles of CD40 in cell-mediated inflammatory responses. Immunology Today 17 10 1996 487 492
23. S. Kumar R. L. Tarleton Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. Journal of Immunology 166 7 2001 4596 4603
24. D. Martin R. Tarleton tarleton@uga.edu Generation, specificity, and function of CD 8+ T cells in Trypanosoma cruzi infection. Immunological Reviews 201 2004 1 304 317
25. J. C. S. Aliberti M. A. G. Cardoso G. A. Martins R. T. Gazzinelli L. Q. Vieira J. S. Silva jsdsilva@fmrp.usp.br Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity 64 6 1996 1961 1967
26. C. A. Hunter christopher.hunter@forsythe.stanford.edu T. Slifer F. Araujo Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infection and Immunity 64 7 1996 2381 2386
27. D. Chaussabel F. Jacobs J. de Jonge CD40 ligation prevents Trypanosoma cruzi infection through interleukin- 12 upregulation. Infection and Immunity 67 4 1999 1929 1934
28. M. Chamekh V. Vercruysse M. Habib Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection. Infection and Immunity 73 10 2005 6552 6561
29. Y. Suzuki M. A. Orellana R. D. Schreiber J. S. Remington Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240 4851 1988 516 518
30. R. T. Gazzinelli M. Wysocka S. Hayashi Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. Journal of Immunology 153 6 1994 2533 2543
31. C. S. Subauste carlos.subauste@uc.edu M. Wessendarp R. U. Sorensen L. E. Leiva CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. Journal of Immunology 162 11 1999 6690 6700
32. G. Reichmann W. Walker E. N. Villegas The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infection and Immunity 68 3 2000 1312 1318
33. C. S. Subauste carlos.subauste@uc.edu M. Wessendarp CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon. Infection and Immunity 74 3 2006 1573 1579
34. W. G. Ferlin T. von der Weid F. Cottrez D. A. Ferrick R. L. Coffman M. C. Howard mhoward@anergen.com The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. European Journal of Immunology 28 2 1998 525 531
35. A. Awasthi R. Mathur A. Khan CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. Journal of Experimental Medicine 197 8 2003 1037 1043
36. G. J. Mazzei M. D. Edgerton C. Losberger Recombinant soluble trimeric CD40 ligand is biologically active. Journal of Biological Chemistry 270 13 1995 7025 7028
37. R. S. Kornbluth The emerging role of CD40 ligand in HIV infection. Journal of Leukocyte Biology 68 3 2000 373 382
38. G. Chen P. A. Darrah D. M. Mosser Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages. Infection and Immunity 69 5 2001 3255 3263
39. W. C. Fanslow S. Srinivasan R. Paxton M. G. Gibson M. K. Spriggs R. J. Armitage Structural characteristics of CD40 ligand that determine biological function. Seminars in Immunology 6 5 1994 267 278
40. R. M. Locksley locksley@medicine.ucsf.edu N. Killeen M. J. Lenardo The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 4 2001 487 501
41. A. E. Morris R. L. Remmele Jr. R. Klinke B. M. Macduff W. C. Fanslow R. J. Armitage Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). Journal of Biological Chemistry 274 1 1999 418 423
42. S. Fournel S. Wieckowski W. Sun C 3 -symmetric peptide scaffolds are functional mimetics of trimeric CD40L. Nature Chemical Biology 1 7 2005 377 382
43. M. Habib M. Noval Rivas M. Chamekh Small CD40L mimetics promote control of parasitemia and enhances T cells producing interferon-γ during experimental Trypanosoma cruzi infection. to appear in Journal of Immunology
44. S. Zambrano-Villa D. Rosales-Borjas J. C. Carrero L. Ortiz-Ortiz librado@servidor.unam.mx How protozoan parasites evade the immune response. Trends in Parasitology 18 6 2002 272 278
45. L. Van Overtvelt N. Vanderheyde V. Verhasselt Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infection and Immunity 67 8 1999 4033 4040
46. L. Planelles M. C. Thomas C. Marãón M. Morell M. C. López mclopez@ipb.csic.es Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clinical and Experimental Immunology 131 1 2003 41 47
47. R. K. Mathur A. Awasthi P. Wadhone B. Ramanamurthy B. Saha sahab@nccs.res.in Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nature Medicine 10 5 2004 540 544
48. K. M. Haas K. A. Taylor N. D. MacHugh J. M. Kreeger D. M. Estes Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection. Journal of Leukocyte Biology 70 6 2001 931 940